Dr. Eugenia Girda, MD
Claim this profileRutgers Cancer Institute of New Jersey
Area of expertise
Ovarian Cancer
Eugenia Girda, MD has run 7 trials for Ovarian Cancer. Some of their research focus areas include:
Cancer
Eugenia Girda, MD has run 6 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
Rutgers Cancer Institute Of New Jersey
Robert Wood Johnson University Hospital Somerset
Clinical Trials Eugenia Girda, MD is currently running
ZN-c3
for Uterine Cancer
This is a Phase 2 study to evaluate the clinical activity and safety of ZN-c3 (azenosertib) in adult women with recurrent or persistent uterine serous carcinoma (USC).
Recruiting
1 award
Phase 2
6 criteria
Herceptin Hylecta or Phesgo + Chemotherapy
for Uterine Cancer
This phase III trial tests whether adding trastuzumab and hyaluronidase-oysk (Herceptin Hylecta \[TM\]) or pertuzumab, trastuzumab and hyaluronidase-zzxf (Phesgo \[TM\]) to the usual chemotherapy (paclitaxel and carboplatin) works to shrink tumors in patients with HER2 positive endometrial cancer. Trastuzumab and pertuzumab are monoclonal antibodies and forms of targeted therapy that attach to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When trastuzumab or pertuzumab attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Hyaluronidase is an endoglycosidase. It helps to keep pertuzumab and trastuzumab in the body longer, so that these medications will have a greater effect. Hyaluronidase also allows trastuzumab and trastuzumab/pertuzumab to be given by injection under the skin and shortens their administration time compared to trastuzumab or pertuzumab alone. Paclitaxel is a taxane and in a class of medications called antimicrotubule agents. It stops tumor cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Giving Herceptin Hylecta or Phesgo in combination with paclitaxel and carboplatin may shrink the tumor and prevent the cancer from coming back in patients with HER2 positive endometrial cancer.
Recruiting
2 awards
Phase 3
More about Eugenia Girda, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Eugenia Girda, MD has experience with
- Paclitaxel
- Carboplatin
- Pembrolizumab
- Atezolizumab
- Bevacizumab
- Nivolumab
Breakdown of trials Eugenia Girda, MD has run
Ovarian Cancer
Cancer
Solid Tumors
Endometrial Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eugenia Girda, MD specialize in?
Eugenia Girda, MD focuses on Ovarian Cancer and Cancer. In particular, much of their work with Ovarian Cancer has involved KRAS positive patients, or patients who are BRCA1 positive.
Is Eugenia Girda, MD currently recruiting for clinical trials?
Yes, Eugenia Girda, MD is currently recruiting for 5 clinical trials in New Brunswick New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Eugenia Girda, MD has studied deeply?
Yes, Eugenia Girda, MD has studied treatments such as Paclitaxel, Carboplatin, Pembrolizumab.
What is the best way to schedule an appointment with Eugenia Girda, MD?
Apply for one of the trials that Eugenia Girda, MD is conducting.
What is the office address of Eugenia Girda, MD?
The office of Eugenia Girda, MD is located at: Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey 08903 United States. This is the address for their practice at the Rutgers Cancer Institute of New Jersey.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.